In vitro neurotoxic Fe(III) and Fe(III)-chelator activities in rat hippocampal cultures. From neurotoxicity to neuroprotection prospects.

[1]  M. Núñez,et al.  Iron toxicity in neurodegeneration , 2012, BioMetals.

[2]  P. Ponka,et al.  Iron overload in human disease. , 2012, The New England journal of medicine.

[3]  Blaine R. Roberts,et al.  The role of metallobiology and amyloid‐β peptides in Alzheimer’s disease , 2012, Journal of neurochemistry.

[4]  R. Squitti.  Metals in Alzheimer's disease: a systemic perspective. , 2012, Frontiers in bioscience.

[5]  Min Li,et al.  Psychological Stress Expands Low Molecular Weight Iron Pool in Cerebral Cortex, Hippocampus, and Striatum of Rats , 2011, Biological Trace Element Research.

[6]  Masataka Kikuchi,et al.  Dysregulation of Iron Metabolism in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis , 2011, Advances in pharmacological sciences.

[7]  Stefan Vogt,et al.  Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease , 2011, NeuroImage.

[8]  F. Codazzi,et al.  Iron handling in hippocampal neurons: activity‐dependent iron entry and mitochondria‐mediated neurotoxicity , 2011, Aging cell.

[9]  Kyle L. Morris,et al.  Iron Promotes the Toxicity of Amyloid β Peptide by Impeding Its Ordered Aggregation* , 2010, The Journal of Biological Chemistry.

[10]  B. Platt,et al.  Aluminum does not enhance β-amyloid toxicity in rat hippocampal cultures , 2010, Brain Research.

[11]  G. Perry,et al.  Getting the iron out: phlebotomy for Alzheimer's disease? , 2009, Medical hypotheses.

[12]  A. Salifoglou,et al.  pH-specific synthetic chemistry and solution studies in the binary system of iron(III) with the alpha-hydroxycarboxylate substrate quinic acid: potential relevance to iron chemistry in plant fluids. , 2009, Inorganic chemistry.

[13]  A. Salifoglou,et al.  Synthetic, structural, spectroscopic and solution speciation studies of the binary Al(III)–quinic acid system. Relevance of soluble Al(III)–hydroxycarboxylate species to molecular toxicity , 2008 .

[14]  K. Blennow,et al.  Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial , 2008, The Lancet Neurology.

[15]  Dong Hyun Kim,et al.  The seed extract of Cassia obtusifolia offers neuroprotection to mouse hippocampal cultures. , 2008, Journal of pharmacological sciences.

[16]  C. Masters,et al.  Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ , 2008, Neuron.

[17]  G. Porto,et al.  Iron overload and immunity. , 2007, World journal of gastroenterology.

[18]  Moussa B. H. Youdim,et al.  Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents , 2007, Progress in Neurobiology.

[19]  Xiongwei Zhu,et al.  Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease , 2007, Neurochemical Research.

[20]  A. Salifoglou,et al.  Differential toxicity of novel aluminium compounds in hippocampal culture. , 2007, Neurotoxicology.

[21]  J. Domingo.  Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. , 2006, Journal of Alzheimer's disease : JAD.

[22]  Mark A. Smith.  Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! , 2006, Journal of Alzheimer's disease : JAD.

[23]  A. Bush,et al.  Amyloid-β Metal Interaction and Metal Chelation , 2005 .

[24]  M. Núñez,et al.  Iron homeostasis in neuronal cells: a role for IREG1 , 2005, BMC Neuroscience.

[25]  P. Doraiswamy,et al.  Current Status of Metals as Therapeutic Targets in Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[26]  M. O. Bostanci,et al.  The neurotoxic effect of iron on pyramidal cell number in rat hippocampus: a stereological study , 2003 .

[27]  M. Baudry,et al.  Iron toxicity in organotypic cultures of hippocampal slices: role of reactive oxygen species , 2003, Journal of neurochemistry.

[28]  A. Salifoglou,et al.  A novel dinuclear species in the aqueous distribution of aluminum in the presence of citrate. , 2003, Inorganic Chemistry.

[29]  A. Salifoglou.  Synthetic and structural carboxylate chemistry of neurotoxic aluminum in relevance to human diseases , 2002 .

[30]  P. Aisen,et al.  Chemistry and biology of eukaryotic iron metabolism. , 2001, The international journal of biochemistry & cell biology.

[31]  K. Suk,et al.  Neuroprotective and neurotrophic effects of quinic acids from Aster scaber in PC12 cells. , 2001, Biological & pharmaceutical bulletin.

[32]  A. Salifoglou,et al.  pH-dependent investigations of vanadium(V)-peroxo-malate complexes from aqueous solutions. In search of biologically relevant vanadium(V)-peroxo species. , 2001, Inorganic chemistry.

[33]  A. Salifoglou,et al.  Synthesis, pH-dependent structural characterization, and solution behavior of aqueous aluminum and gallium citrate complexes. , 2001, Inorganic chemistry.

[34]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[35]  Ashley I. Bush,et al.  Redox-active iron mediates amyloid-β toxicity , 2001 .

[36]  W. Linert,et al.  The oxidation of 6-hydroxydopamine in aqueous solution. Part 1. The formation of three metastable quinones at low pH , 2001 .

[37]  C. Enns,et al.  Iron homeostasis: new tales from the crypt. , 2000, Blood.

[38]  H. Kwon,et al.  A new caffeoyl quinic acid from aster scaber and its inhibitory activity against human immunodeficiency virus-1 (HIV-1) integrase. , 2000, Chemical & pharmaceutical bulletin.

[39]  Xudong Huang,et al.  The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.

[40]  A. Salifoglou,et al.  Synthesis, Spectroscopic and Structural Characterization of the First Mononuclear, Water Soluble Iron−Citrate Complex, (NH4)5Fe(C6H4O7)2·2H2O , 1998 .

[41]  K. Hase,et al.  Potent antihepatotoxic activity of dicaffeoyl quinic acids from propolis. , 1996, Biological & pharmaceutical bulletin.

[42]  E. Haslam,et al.  Shikimic Acid: Metabolism and Metabolites , 1993 .

[43]  R. Bentley,et al.  The shikimate pathway--a metabolic tree with many branches. , 1990, Critical reviews in biochemistry and molecular biology.

[44]  H. Keberle.  The Biochemistry of Desferrioxamine and its Relation to Iron Metabolism , 1964, Annals of the New York Academy of Sciences.